Preliminary standardization of lashuna A potential drug for postmenopausal osteoporosis.


Lashuna, Osteoporosis, Post Menopause

How to Cite

T. R. Thanga, S. K., Sujan, S., Patharkar, J., & Modi, M. (2018). Preliminary standardization of lashuna A potential drug for postmenopausal osteoporosis. Ayurlog: National Journal of Research in Ayurved Science, 6(3). Retrieved from


Osteoporosis is a major international health problem, accentuated by increasing longevity. Osteoporosis as “a systemic skeletal disease characterized by low bone mass and bone architectural leading to increased riskâ€. Menopause is the normal process but now a day it becoming the major health problem in developing countries like India.   In Ayurveda Menopause deals with jarapakvaavasta of the body Jara and Rajonivritti are manifested due to the progressive reduction in the functional ability of Agnis, which results in an inadequate tissue nutrition. This nutritional imbalance triggers the irreversible degenerative changes in „Sapta Dhatus‟. The disease Osteoporosis is somewhat similar to the description of Asthi Kshaya in which metabolism of Asthi Dhatu is disturbed. Rasayana therapy has proved efficacious in managing and preventing many chronic conditions till date. As Postmenopausal Osteoporosis is a disease related to aging, Rasayana can provide the better alternative to increasing quality of life. Here, the drug Lashuna also one of the Rasayana guna dravya.



I  declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein. All agreed to the terms and conditions, Privacy Policy, which is declared on Journal Website and online filled (uploaded) form



Download data is not yet available.